跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LAMICTAL lamotrigine 50 mg dispersible/chewable tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
LAMICTAL lamotrigine 50 mg dispersible/chewable tablet bottle
Approved
STANDARD
LAMICTAL lamotrigine 50 mg dispersible/chewable tablet bottle
Aspen Pharmacare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
19fabc3667b8a684
Company
Aspen Pharmacare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
19fabc3667b8a684
Product Name
LAMICTAL lamotrigine 50 mg dispersible/chewable tablet bottle
Artg Id
59996
Artg Name
LAMICTAL lamotrigine 50 mg dispersible/chewable tablet bottle
Sponsor
Aspen Pharmacare Australia Pty Ltd
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Artg Date
1997-05-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2013-PI-01024-1
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
19fabc3667b8a684
Type
Standard
Back to TGA Approvals